Success Metrics

Clinical Success Rate
93.3%

Based on 14 completed trials

Completion Rate
93%(14/15)
Active Trials
4(17%)
Results Posted
7%(1 trials)
Terminated
1(4%)

Phase Distribution

Ph not_applicable
8
35%
Ph phase_3
1
4%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

93.3%

14 of 15 finished

Non-Completion Rate

6.7%

1 ended early

Currently Active

4

trials recruiting

Total Trials

23

all time

Status Distribution
Active(4)
Completed(14)
Terminated(1)
Other(4)

Detailed Status

Completed14
Recruiting4
unknown4
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
4
Success Rate
93.3%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (11.1%)
N/A8 (88.9%)

Trials by Status

recruiting417%
completed1461%
terminated14%
unknown417%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT04798352Not Applicable

Follow-up Study in French Practice to Evaluate Improvements in Walking and Pain Relief in Patients Treated With Endovascular Treatment of de Novo Lesions of the Femoropopliteal Artery Above the Knee With LUTONIX®035 or RANGER TM Active Ballon

Completed
NCT07362316

Longitudinal Evaluation of Neuromuscular Involvement in Type 1 Myotonic Dystrophy

Completed
NCT05164744

Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

Recruiting
NCT04053166Not Applicable

Individualized Physical Activity and Carotid Plaque Instability

Completed
NCT02538575Not Applicable

6 Minute Walk Test in Cystic Fibrosis

Completed
NCT01774682Phase 3

Kinematics of Obese Patients Perambulation

Completed
NCT07074028Not Applicable

Characterization and Longitudinal Monitoring of Muscular Phenotype in Patients Admitted to Intensive Care for Sepsis

Recruiting
NCT04864899Not Applicable

Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR)

Completed
NCT04086953Not Applicable

Validation of a Walk-Time Limit Test (WTLT) Derived from the 6-Minute Walk Test (6-MWT) in Patients with Chronic Cardiovascular or Respiratory Diseases

Terminated
NCT06704750

Correlation Between Physical Fitness Status and Quality of Postoperative Recovery in Gynaecological ERAS Patients

Completed
NCT05784571

Assessment of Body Composition and Physical Function

Completed
NCT03323216

BIO-2-HEART: Identification of Biomarkers in T2DM and Heart Failure

Recruiting
NCT04145778

Evaluation of the Muscular FORCE in the Upper Limbs of Patients Presenting a Thoracic Outlet Syndrome

Recruiting
NCT06184763

Evolution of the 6-minute Walk Test in Patients Treated With ELEXACAFTOR / TEZACAFTOR / IVACAFTOR

Unknown
NCT05963919

Determinants of Functional Capacity in Children With Asthma

Completed
NCT05771506

Determinants of Balance in Patients With Chronic Obstructive Pulmonary Disease

Completed
NCT04864132

The Investigation Of Exercise Capacity And Exercise-Induced Fatigue in Young Adults Who Survived From Coronavirus

Completed
NCT03400839

Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases

Unknown
NCT03905161

Rhythmic Auditory Stimulation and Walking Speed in the 6-minute Walk Test

Completed
NCT03069625Not Applicable

Sit-to-stand Test in Cystic Fibrosis Children and Adolescents

Completed

Drug Details

Intervention Type
OTHER
Total Trials
23